Administering GPRC5D therapy: Dosing and Monitoring for CRS & ICANS

Opinion
Video

Experts explain the administration of step-up and treatment doses for GPRC5D at your institution, including whether they are given in clinic or in the community, and will discuss how patients are monitored for cytokine release syndrome and immune effector cell–associated neurotoxicity syndrome during the step-up phase.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.